338 related articles for article (PubMed ID: 10911368)
21. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.
Jansen G; Mauritz RM; Assaraf YG; Sprecher H; Drori S; Kathmann I; Westerhof GR; Priest DG; Bunni M; Pinedo HM; Schornagel JH; Peters GJ
Adv Enzyme Regul; 1997; 37():59-76. PubMed ID: 9381986
[TBL] [Abstract][Full Text] [Related]
22. pH dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells. Further evidence for a third route mediated at low pH.
Sierra EE; Brigle KE; Spinella MJ; Goldman ID
Biochem Pharmacol; 1997 Jan; 53(2):223-31. PubMed ID: 9037255
[TBL] [Abstract][Full Text] [Related]
23. The issues of transport multiplicity and energetics pertaining to methotrexate efflux in L1210 cells addressed by an analysis of cis and trans effects of inhibitors.
Sirotnak FM; O'Leary DF
Cancer Res; 1991 Mar; 51(5):1412-7. PubMed ID: 1997179
[TBL] [Abstract][Full Text] [Related]
24. Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo.
Mauritz R; Peters GJ; Kathmann I; Teshale H; Noordhuis P; Comijn EM; Pinedo HM; Jansen G
Cancer Chemother Pharmacol; 2008 Nov; 62(6):937-48. PubMed ID: 18283461
[TBL] [Abstract][Full Text] [Related]
25. A prominent low-pH methotrexate transport activity in human solid tumors: contribution to the preservation of methotrexate pharmacologic activity in HeLa cells lacking the reduced folate carrier.
Zhao R; Gao F; Hanscom M; Goldman ID
Clin Cancer Res; 2004 Jan; 10(2):718-27. PubMed ID: 14760095
[TBL] [Abstract][Full Text] [Related]
26. Reduced folate carrier: tissue distribution and effects of chronic ethanol intake in the micropig.
Villanueva JA; Devlin AM; Halsted CH
Alcohol Clin Exp Res; 2001 Mar; 25(3):415-20. PubMed ID: 11290853
[TBL] [Abstract][Full Text] [Related]
27. Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier system.
Fry DW; Besserer JA; Boritzki TJ
Cancer Res; 1984 Aug; 44(8):3366-70. PubMed ID: 6547636
[TBL] [Abstract][Full Text] [Related]
28. A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance.
Jansen G; Mauritz R; Drori S; Sprecher H; Kathmann I; Bunni M; Priest DG; Noordhuis P; Schornagel JH; Pinedo HM; Peters GJ; Assaraf YG
J Biol Chem; 1998 Nov; 273(46):30189-98. PubMed ID: 9804775
[TBL] [Abstract][Full Text] [Related]
29. Preservation of folate transport activity with a low-pH optimum in rat IEC-6 intestinal epithelial cell lines that lack reduced folate carrier function.
Wang Y; Rajgopal A; Goldman ID; Zhao R
Am J Physiol Cell Physiol; 2005 Jan; 288(1):C65-71. PubMed ID: 15385270
[TBL] [Abstract][Full Text] [Related]
30. Impact of overexpression of the reduced folate carrier (RFC1), an anion exchanger, on concentrative transport in murine L1210 leukemia cells.
Zhao R; Seither R; Brigle KE; Sharina IG; Wang PJ; Goldman ID
J Biol Chem; 1997 Aug; 272(34):21207-12. PubMed ID: 9261128
[TBL] [Abstract][Full Text] [Related]
31. Functional characterization of PCFT/HCP1 as the molecular entity of the carrier-mediated intestinal folate transport system in the rat model.
Inoue K; Nakai Y; Ueda S; Kamigaso S; Ohta KY; Hatakeyama M; Hayashi Y; Otagiri M; Yuasa H
Am J Physiol Gastrointest Liver Physiol; 2008 Mar; 294(3):G660-8. PubMed ID: 18174275
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of folate analogue transport inward in L1210 cells during methotrexate therapy of leukemic mice: evidence of the nature of the effect, possible host mediation, and pharmacokinetic significance.
Sirotnak FM; Poser RE; Barrueco JR
Cancer Res; 1987 Oct; 47(20):5334-9. PubMed ID: 3498533
[TBL] [Abstract][Full Text] [Related]
33. The mechanism of folate transport in rabbit reticulocytes.
Bobzien WF; Goldman ID
J Clin Invest; 1972 Jul; 51(7):1688-96. PubMed ID: 5032520
[TBL] [Abstract][Full Text] [Related]
34. Quantitative evaluation of the drug-drug interactions between methotrexate and nonsteroidal anti-inflammatory drugs in the renal uptake process based on the contribution of organic anion transporters and reduced folate carrier.
Nozaki Y; Kusuhara H; Endou H; Sugiyama Y
J Pharmacol Exp Ther; 2004 Apr; 309(1):226-34. PubMed ID: 14722319
[TBL] [Abstract][Full Text] [Related]
35. The reduced folate carrier gene is a novel selectable marker for recombinant protein overexpression.
Rothem L; Berman B; Stark M; Jansen G; Assaraf YG
Mol Pharmacol; 2005 Sep; 68(3):616-24. PubMed ID: 15939798
[TBL] [Abstract][Full Text] [Related]
36. Transport of methotrexate into PC-3 human prostate cancer cells.
Horne DW; Reed KA
Arch Biochem Biophys; 2001 Oct; 394(1):39-44. PubMed ID: 11566025
[TBL] [Abstract][Full Text] [Related]
37. Expression of the reduced folate carrier SLC19A1 in IEC-6 cells results in two distinct transport activities.
Rajgopal A; Sierra EE; Zhao R; Goldman ID
Am J Physiol Cell Physiol; 2001 Nov; 281(5):C1579-86. PubMed ID: 11600421
[TBL] [Abstract][Full Text] [Related]
38. Carrier-mediated membrane transport of folates in mammalian cells.
Sirotnak FM; Tolner B
Annu Rev Nutr; 1999; 19():91-122. PubMed ID: 10448518
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of reduced folate carrier gene (RFC1) expression after exposure to methotrexate in ZR-75-1 breast cancer cells.
Ma D; Huang H; Moscow JA
Biochem Biophys Res Commun; 2000 Dec; 279(3):891-7. PubMed ID: 11162445
[TBL] [Abstract][Full Text] [Related]
40. Carrier-mediated hepatobiliary transport of a novel antifolate, N-[4-[(2,4-dianninopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-homoglutamic acid, in rats.
Han YH; Kato Y; Watanabe Y; Terao K; Asoh Y; Sugiyama Y
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):394-400. PubMed ID: 11259322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]